These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27354289)

  • 1. False-negative direct immunofluorescence testing in vancomycin-induced linear IgA bullous dermatosis: a diagnostic pitfall.
    Winn AE; Spillane EL; Peterson DJ; Sperling LC; Meyerle JH
    J Cutan Pathol; 2016 Sep; 43(9):802-4. PubMed ID: 27354289
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
    Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
    Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear IgA bullous dermatosis: a rare side effect of vancomycin.
    Selvaraj PK; Khasawneh FA
    Ann Saudi Med; 2013; 33(4):397-9. PubMed ID: 22750770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral vancomycin-induced linear IgA bullous dermatosis.
    Belhareth K; Soua Y; Hraeich A; Fredj NB; Badreddine S; Ali HB; Zili J
    Indian J Dermatol Venereol Leprol; 2019; 85(6):621-622. PubMed ID: 31571615
    [No Abstract]   [Full Text] [Related]  

  • 5. Vancomycin-induced linear IgA bullous dermatosis.
    Navarro-Bielsa A; Abadías-Granado I; Gomez-Mateo MC; Gilaberte Y
    Med Clin (Barc); 2022 Jul; 159(2):107. PubMed ID: 35660288
    [No Abstract]   [Full Text] [Related]  

  • 6. Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
    Choudhry SZ; Kashat M; Lim HW
    Int J Dermatol; 2015 Nov; 54(11):1211-3. PubMed ID: 26227580
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
    Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
    Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blister fluid is a useful diagnostic tool for diagnosis of vancomycin-induced linear IgA bullous dermatosis.
    Yoshida K; Yoshihama E; Morii K; Ishiko A
    J Dermatol; 2021 Nov; 48(11):e543-e544. PubMed ID: 34368986
    [No Abstract]   [Full Text] [Related]  

  • 10. Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Tomida E; Kato Y; Ozawa H; Hasegawa H; Ishii N; Hashimoto T; Akiyama M
    Br J Dermatol; 2016 Nov; 175(5):1106-1108. PubMed ID: 26265104
    [No Abstract]   [Full Text] [Related]  

  • 11. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
    Nguyen JK; Koshelev MV; Gill BJ; Boulavsky J; Diwan AH; Dao H
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
    Nasr J; Ammoury A; Chouairy C; Mégarbané H; El Habr C
    J Med Liban; 2014; 62(3):176-9. PubMed ID: 25306799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.
    Pereira AR; Moura LH; Pinheiro JR; Pasin VP; Enokihara MM; Porro AM
    An Bras Dermatol; 2016; 91(5 suppl 1):35-38. PubMed ID: 28300888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-Induced Linear IgA Bullous Dermatosis.
    Go JR; Abu Saleh OM
    N Engl J Med; 2020 Oct; 383(16):1577. PubMed ID: 33053287
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    Adachi M; Adachi T; Yokota M; Ichimura C; Yoshida K; Ishii K; Ishiko A
    J Dermatol; 2021 Dec; 48(12):e610-e611. PubMed ID: 34561902
    [No Abstract]   [Full Text] [Related]  

  • 16. Linear IgA bullous dermatosis mimicking a neutrophilic dermatosis.
    Dietrich N; Beltraminelli H; Borradori L
    Eur J Dermatol; 2012; 22(5):713-4. PubMed ID: 22913880
    [No Abstract]   [Full Text] [Related]  

  • 17. SnapshotDx Quiz: July 2018.
    Berg SA; Chu EY
    J Invest Dermatol; 2018 Jul; 138(7):e47. PubMed ID: 29941099
    [No Abstract]   [Full Text] [Related]  

  • 18. Cephalosporin-induced linear IgA dermatosis in a child: Case report and literature review.
    Sarikaya Solak S; Ficicioglu S
    Dermatol Ther; 2019 Jul; 32(4):e12927. PubMed ID: 30977941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear IgA bullous dermatosis due to vancomycin and cutaneous necrosis due to terlipressin in the same patient.
    Castellanos-González M; Marzal-Alfaro MB; Díaz-Sánchez A; Martos MG
    Indian J Dermatol Venereol Leprol; 2016; 82(6):723-726. PubMed ID: 27643543
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    Tashima S; Konishi K; Koga H; Hashimoto T
    Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.